Alnylam to Contribute IP to Tropical Disease Research Effort
July 08, 2009
Alnylam to Contribute IP to Tropical Disease Research Effort
Alnylam will contribute more than 1,500 issued or pending patents covering RNA interference technology to a patent pool for neglected tropical diseases.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Isis TTR Amyloidosis Drug Fast Tracked by FDA
December 13, 2012 / Gene Silencing News - With Three Years of Cash in the Bank, Regulus Aims for Two INDs by 2014
November 29, 2012 / Gene Silencing News - Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News - Alnylam Receives $3.2M Milestone from GSK Under Vaccine Collaboration
August 2, 2012 / Gene Silencing News - As Evidence Grows for Role of microRNAs in Disease, Drugmakers Focus on Select Targets
December 16, 2010 / Gene Silencing News